103 related articles for article (PubMed ID: 26923360)
1. Triplex forming oligonucleotides targeted to hmga1 selectively inhibit its expression and induce apoptosis in human cervical cancer.
Akhter MZ; Rajeswari MR
J Biomol Struct Dyn; 2017 Mar; 35(4):689-703. PubMed ID: 26923360
[TBL] [Abstract][Full Text] [Related]
2. Interaction of adriamycin with a promoter region of hmga1 and its inhibitory effect on HMGA1 expression in A431 human squamous carcinoma cell line.
Akhter MZ; Sharma A; Rajeswari MR
Mol Biosyst; 2011 Apr; 7(4):1336-46. PubMed ID: 21336378
[TBL] [Abstract][Full Text] [Related]
3. Molecular aspects on adriamycin interaction with hmga1 regulatory region and its inhibitory effect on HMGA1 expression in human cervical cancer.
Akhter MZ; Luthra K; Rajeswari MR
J Biomol Struct Dyn; 2016; 34(4):877-91. PubMed ID: 26084422
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells.
Napoli S; Negri U; Arcamone F; Capobianco ML; Carbone GM; Catapano CV
Nucleic Acids Res; 2006; 34(2):734-44. PubMed ID: 16449206
[TBL] [Abstract][Full Text] [Related]
5. Interaction of doxorubicin with a regulatory element of hmga1 and its in vitro anti-cancer activity associated with decreased HMGA1 expression.
Akhter MZ; Rajeswari MR
J Photochem Photobiol B; 2014 Dec; 141():36-46. PubMed ID: 25313540
[TBL] [Abstract][Full Text] [Related]
6. An efficient antigene activity and antiproliferative effect by targeting the Bcl-2 or survivin gene with triplex forming oligonucleotides containing a W-shaped nucleoside analogue (WNA-βT).
Taniguchi Y; Sasaki S
Org Biomol Chem; 2012 Oct; 10(41):8336-41. PubMed ID: 22987068
[TBL] [Abstract][Full Text] [Related]
7. Targeting and regulation of the HER-2/neu oncogene promoter with bis-peptide nucleic acids.
Ziemba AJ; Zhilina ZV; Krotova-Khan Y; Stankova L; Ebbinghaus SW
Oligonucleotides; 2005; 15(1):36-50. PubMed ID: 15788899
[TBL] [Abstract][Full Text] [Related]
8. Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models.
Trapasso F; Sarti M; Cesari R; Yendamuri S; Dumon KR; Aqeilan RI; Pentimalli F; Infante L; Alder H; Abe N; Watanabe T; Viglietto G; Croce CM; Fusco A
Cancer Gene Ther; 2004 Sep; 11(9):633-41. PubMed ID: 15272314
[TBL] [Abstract][Full Text] [Related]
9. Targeting bcl-2 by triplex-forming oligonucleotide--a promising carrier for gene-radiotherapy.
Shen C; Rattat D; Buck A; Mehrke G; Polat B; Ribbert H; Schirrmeister H; Mahren B; Matuschek C; Reske SN
Cancer Biother Radiopharm; 2003 Feb; 18(1):17-26. PubMed ID: 12667305
[TBL] [Abstract][Full Text] [Related]
10. The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors.
Hillion J; Roy S; Heydarian M; Cope L; Xian L; Koo M; Luo LZ; Kellyn K; Ronnett BM; Huso T; Armstrong D; Reddy K; Huso DL; Resar LMS
Gynecol Oncol; 2016 Jun; 141(3):580-587. PubMed ID: 27001612
[TBL] [Abstract][Full Text] [Related]
11. (A,G)-oligonucleotides form extraordinary stable triple helices with a critical R.Y sequence of the murine c-Ki-ras promoter and inhibit transcription in transfected NIH 3T3 cells.
Alunni-Fabbroni M; Pirulli D; Manzini G; Xodo LE
Biochemistry; 1996 Dec; 35(50):16361-9. PubMed ID: 8973212
[TBL] [Abstract][Full Text] [Related]
12. High-mobility group A1 proteins inhibit expression of nucleotide excision repair factor xeroderma pigmentosum group A.
Adair JE; Maloney SC; Dement GA; Wertzler KJ; Smerdon MJ; Reeves R
Cancer Res; 2007 Jul; 67(13):6044-52. PubMed ID: 17616660
[TBL] [Abstract][Full Text] [Related]
13. Human KIT ligand promoter is positively regulated by HMGA1 in breast and ovarian cancer cells.
Treff NR; Dement GA; Adair JE; Britt RL; Nie R; Shima JE; Taylor WE; Reeves R
Oncogene; 2004 Nov; 23(52):8557-62. PubMed ID: 15378028
[TBL] [Abstract][Full Text] [Related]
14. Expression of miR‑26a exhibits a negative correlation with HMGA1 and regulates cancer progression by targeting HMGA1 in lung adenocarcinoma cells.
Sekimoto N; Suzuki A; Suzuki Y; Sugano S
Mol Med Rep; 2017 Feb; 15(2):534-542. PubMed ID: 28000891
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional control of the human high mobility group A1 gene: basal and oncogenic Ras-regulated expression.
Cleynen I; Huysmans C; Sasazuki T; Shirasawa S; Van de Ven W; Peeters K
Cancer Res; 2007 May; 67(10):4620-9. PubMed ID: 17510387
[TBL] [Abstract][Full Text] [Related]
16. DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene.
Carbone GM; McGuffie E; Napoli S; Flanagan CE; Dembech C; Negri U; Arcamone F; Capobianco ML; Catapano CV
Nucleic Acids Res; 2004; 32(8):2396-410. PubMed ID: 15121897
[TBL] [Abstract][Full Text] [Related]
17. High-mobility group A1 (HMGA1) protein expression correlates with cisplatin-induced cell death in squamous cell carcinoma of skin.
Sharma A; Ray R; Rajeswari MR
Cancer Invest; 2010 May; 28(4):340-9. PubMed ID: 19916743
[TBL] [Abstract][Full Text] [Related]
18. High mobility group A1 and cancer: potential biomarker and therapeutic target.
Shah SN; Resar LM
Histol Histopathol; 2012 May; 27(5):567-79. PubMed ID: 22419021
[TBL] [Abstract][Full Text] [Related]
19. Intercalator conjugates of pyrimidine locked nucleic acid-modified triplex-forming oligonucleotides: improving DNA binding properties and reaching cellular activities.
Brunet E; Corgnali M; Perrouault L; Roig V; Asseline U; Sørensen MD; Babu BR; Wengel J; Giovannangeli C
Nucleic Acids Res; 2005; 33(13):4223-34. PubMed ID: 16049028
[TBL] [Abstract][Full Text] [Related]
20. Improved bioactivity of G-rich triplex-forming oligonucleotides containing modified guanine bases.
Rogers FA; Lloyd JA; Tiwari MK
Artif DNA PNA XNA; 2014; 5(1):e27792. PubMed ID: 25483840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
